POPULAR WEIGHT-LOSS DRUGS LINKED TO HORRIFIC INJURIES, BLINDNESS AS LAWSUITS EXPLODE
They were just trying to get healthy. Now they are permanently broken—and they blame the blockbuster drugs in millions of medicine cabinets.
A Maryland truck driver is BLIND after suffering back-to-back “eye strokes.” An Oklahoma grandmother heard her own colon explode while driving her granddaughter home. A Louisiana woman vomited for weeks until a brain injury stole her mind.
These are not freak accidents. They are the faces of a legal firestorm targeting the makers of Ozempic, Wegovy, and Mounjaro. Thousands of patients are now suing, claiming the drug giants FAILED to warn them about catastrophic risks hidden behind the promise of weight loss.
The numbers are staggering. Court documents reveal that among the federal lawsuits:
- 75% allege gastroparesis, or stomach paralysis.
- 18% accuse the drugs of causing ileus, where the bowels STOP working.
- At least 110 people claim the medications triggered sudden blindness or severe vision damage.
“My colon blew up. Literally blew up,” said JoHelen McClain, the Oklahoma real estate agent who now lives with a colostomy bag after her rupture. Todd Engel, the truck driver, woke up one day blind in one eye, then the other. “I wake up in the dark, and I go to sleep in the dark,” he said.
The drug companies are fighting back. Novo Nordisk and Eli Lilly insist their FDA-approved labels are adequate and that the drugs’ safety profile is “well-established.” They vow to vigorously defend the medications.
But internal court figures tell a different story—one of escalating suffering. A USA TODAY review of lawsuits found patients alleging not just stomach problems but gangrenous gallbladders, chronic obstructions, and a severe neurological condition causing permanent confusion.
Critics say the warning labels have been playing catch-up. Ozempic’s label was only updated to include “ileus” in late 2023, AFTER the first lawsuits were filed. A European label now mentions the blindness risk; the U.S. label does not.
“What happened to me should have never happened,” said Todd Engel.
While doctors and studies affirm the drugs’ benefits for millions, a terrifying pattern is emerging from the court filings: regular people who took a medication for a common problem, only to have their bodies turn against them in the most violent ways imaginable.
The first major test trials won’t begin until 2027. Until then, the prescriptions keep soaring, fueled by celebrity endorsements and viral success stories.
The truth is buried in the fine print the patients never saw, and the bill for America’s miracle weight-loss cure is coming due in blood and shattered lives.




